Efficacy of Sichong tablet in the treatment of deep venous thrombosis in the Internet plus mode

Phase 4

Recruiting

• Conditions: Deep venous thrombosis of lower extremity

• Registration Number: ITMCTR2100004983
• Lead Sponsor: Affiliated Hospital of Shandong University of traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) According to the diagnostic criteria of DVT.
(2) Stage belongs to chronic patients.
(3) aged from 18 to 70 years old.
(4) Smart phone users.
(5) Voluntary participation and cooperation with researchers, signed informed consent.

Exclusion Criteria

(1) Allergic or other adverse reactions to Sichong tablet or rivaroxaban.
(2) Patients with coagulation dysfunction, anemia, and platelet disorders.
(3) Patients with hemorrhagic disease in recent 3 months.
(4) There are peptic ulcer, malignant tumor, esophageal varices, arteriovenous malformation, hemangioma and other patients with the risk of massive bleeding.
(5) Patients with heart, brain and lung diseases and abnormal liver and kidney functions.
(6) Thromboangitis, arteritis, Renault syndrome and other inflammatory vascular diseases.
(7) Pregnant and lactating women.
(8) Previous or existing mental disorders.
(9) Poor compliance, difficult to cooperate with the treatment.
(10) Incomplete information affects the judge.
(11) Chinese and Western drugs or other drug experimenters who are taking part in the treatment of the disease are being used within two weeks.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
platelet;hemoglobin;Venorectomy score;Fibrinogen;Venous recanalization rate;activated partial thromboplastin time;Prothrombin time;aspartate aminotransferase;creatinine;Symptom quantification score;Curative effect of traditional Chinese medical Syndrome;Alanine aminotransferase;Venous insufficiency quality of life scale score;